Medical Properties Trust, Inc. (MPW)
NYSE: MPW · Real-Time Price · USD
4.310
+0.070 (1.65%)
Nov 22, 2024, 4:00 PM EST - Market closed
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for MPW stock have an average target of 5.50, with a low estimate of 4.00 and a high estimate of 7.00. The average target predicts an increase of 27.61% from the current stock price of 4.31.
Analyst Consensus: Hold
* Price targets were last updated on Sep 13, 2024.
Analyst Ratings
The average analyst rating for MPW stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 0 | 0 | 0 |
| Hold | 7 | 8 | 8 | 7 | 7 | 6 |
| Sell | 4 | 4 | 4 | 2 | 2 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 10 | 10 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | +39.21% | Sep 13, 2024 |
| Colliers Securities | Colliers Securities | Hold → Strong Buy Upgrades $6.5 | Hold → Strong Buy | Upgrades | $6.5 | +50.81% | Sep 13, 2024 |
| Exane BNP Paribas | Exane BNP Paribas | Buy → Hold Downgrades $6 → $4 | Buy → Hold | Downgrades | $6 → $4 | -7.19% | Jul 2, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $4.5 → $5 | Hold | Maintains | $4.5 → $5 | +16.01% | May 30, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $5 | Buy → Hold | Downgrades | $5 | +16.01% | May 14, 2024 |
Financial Forecast
Revenue This Year
1.03B
Revenue Next Year
981.67M
from 1.03B
Decreased by -4.60%
EPS This Year
-1.74
from -0.93
EPS Next Year
0.27
from -1.74
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.1B | 1.1B | 1.2B | ||
| Avg | 1.0B | 981.7M | 1.0B | ||
| Low | 980.6M | 883.4M | 894.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 10.1% | 25.6% | ||
| Avg | - | -4.6% | 5.2% | ||
| Low | - | -14.2% | -8.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.80 | 0.58 | 0.44 |
| Avg | -1.74 | 0.27 | 0.25 |
| Low | -1.71 | -0.02 | 0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 62.9% |
| Avg | - | - | -8.0% |
| Low | - | - | -81.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.